Clinical Trial

Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues

Recruiting
View on ClinicalTrials.gov →
Summary
Electronic cigarettes are battery-operated devices that can produce an aerosol by heating a liquid which commonly contains nicotine. In recent years, products containing synthetically produced nicotine and nicotine analogues have entered the market. However, it remains unclear whether these types of nicotine have the same effects as conventional nicotine derived from the tobacco plant. The aim of this study is to investigate the effects of these nicotine types and to gain a better understanding of their respective mechanisms of action.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-07
Trial Details
NCT Number NCT07348224
Lead Sponsor Insel Gruppe AG, University Hospital Bern
Collaborators: Swiss Tobacco Prevention Funds
Conditions Nicotine, Vaping, Synthetic Nicotine, Nicotine Analogues
Enrollment 24 participants
Start Date 2026-08-05
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-06